Inventor · disambiguated record
Zhongmin Wang
Also filed as: WANG ZHONGMIN · WANG ZHONGMIN MAXWELL
27 granted patents·38 pending applications·52 citations·filing 2001–2024
94Inventor score
Files withAKESO BIOPHARMA INC32AKESO PHARMACEUTICALS INC5WANG ZHONGMIN5CTTQ AKESO SHANGHAI BIOMED TECH CO LTD3AD PHARMACEUTICAL CO INC2
Top patents by PatentIndex Score
65 records- 0194US12195527B2Anti-PD-1/VEGFA bifunctional antibody, pharmaceutical composition thereofAKESO BIOPHARMA INC·Filed 2023·Granted Jan 14, 2025·2 cites·24 claims
- 0291US11578128B2Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO PHARMACEUTICALS INC·Filed 2017·Granted Feb 14, 2023·7 cites·29 claims
- 0391US10449251B2Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and usesAKESO BIOPHARMA INC·Filed 2015·Granted Oct 22, 2019·6 cites·20 claims
- 0484US10363825B2Method, battery management system and vehicle for charging awakeningBORGWARD TRADEMARK HOLDINGS GMBH·Filed 2017·Granted Jul 30, 2019·9 cites·14 claims
- 0583US12076398B2Anti-PD1 monoclonal antibody, pharmaceutical composition thereof and use thereofCTTQ AKESO SHANGHAI BIOMED TECH CO LTD·Filed 2017·Granted Sep 3, 2024·3 cites·6 claims
- 0681US2025223346A1Monoclonal antibody against nerve growth factor, and encoding gene and use thereofAKESO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0781US2025197487A1Anti-pd-1/vegfa bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0880US11136413B2PDL-1 antibody, pharmaceutical composition thereof, and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Oct 5, 2021·1 cites·40 claims
- 0979US10670604B2PCSK9 antibody, and pharmaceutical composition and use thereofAD PHARMACEUTICAL CO INC·Filed 2016·Granted Jun 2, 2020·2 cites·12 claims
- 1079US10229503B2Methods and systems for splitting merged objects in detected blobs for video analyticsQUALCOMM INC·Filed 2017·Granted Mar 12, 2019·3 cites·30 claims
- 1178US11402383B2Nucleic acid encoding PCSK9 antibodyAD PHARMACEUTICAL CO INC·Filed 2020·Granted Aug 2, 2022·1 cites·19 claims
- 1278US10465014B2PDL-1 antibody, pharmaceutical composition thereof, and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 5, 2019·1 cites·64 claims
- 1378US7662607B2Chalaropsis lysozyme protein and its method of use in anti-bacterial applicationsNEW CENTURY PHARMACEUTICALS·Filed 2004·Granted Feb 16, 2010·5 cites·2 claims
- 1477US12447208B2Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and usesAKESO BIOPHARMA INC·Filed 2022·Granted Oct 21, 2025·0 cites·14 claims
- 1577US11479608B2Anti-CTLA4 antibodiesAKESO BIOPHARMA INC·Filed 2017·Granted Oct 25, 2022·1 cites·24 claims
- 1675US2024025983A1Monoclonal antibody against nerve growth factor, and encoding gene and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1775US2025041409A1Anti-pd1 monoclonal antibody, pharmaceutical composition thereof and use thereofCTTQ AKESO SHANGHAI BIOMED TECH CO LTD·Filed 2024·Application pending·0 cites
- 1873US12479919B2Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO PHARMACEUTICALS INC·Filed 2022·Granted Nov 25, 2025·0 cites·22 claims
- 1973US12390458B2Therapeutic combination of quinoline derivative and antibodyCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 19, 2025·1 cites·14 claims
- 2073US10269135B2Methods and systems for performing sleeping object detection in video analyticsQUALCOMM INC·Filed 2017·Granted Apr 23, 2019·2 cites·30 claims
- 2172USD974421SMug heat press machineWANG ZHONGMIN·Filed 2021·Granted Jan 3, 2023·5 cites·1 claims
- 2272US2025368735A1Bispecific antibody containing anti-cldn18.2 antibody, and pharmaceutical composition and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2372US2025376517A1Anti-cldn18.2 antibody, and pharmaceutical composition and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2470US11701755B2Abrasive articles including a saturant and an anti-loading size layer3M INNOVATIVE PROPERTIES COMPANY·Filed 2018·Granted Jul 18, 2023·0 cites·16 claims
- 2570US11291720B2Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and usesAKESO BIOPHARMA INC·Filed 2019·Granted Apr 5, 2022·0 cites·35 claims
- 2669US2024392040A1Anti-lag3 bispecific antibody, pharmaceutical composition and useAKESO HUIKE SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 2769US2025042995A1Anti-lag3 antibody, pharmaceutical composition and useAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2868US2021340239A1Anti-pd-1/vegfa bifunctional antibody, pharmaceutical composition thereof and use thereofAKESO BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 2964US12286473B2Anti-IL-1β antibody and pharmaceutical composition thereof and use of sameAKESO BIOPHARMA INC·Filed 2019·Granted Apr 29, 2025·0 cites·21 claims
- 3064US2025304703A1Anti-human il-4ra antibody and application thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3163US11680095B2Monoclonal antibody against nerve growth factor, and encoding gene and use thereofAKESO BIOPHARMA INC·Filed 2019·Granted Jun 20, 2023·0 cites·21 claims
- 3263US2024117051A1Therapeutic combination and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3363US2025129163A1Pharmaceutical composition and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3463US2025034253A1Pharmaceutical composition comprising anti-tigit antibody and anti-pd-1/anti-vegfa bispecific antibody, and use thereofAKESO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3562US2025188164A1Pharmaceutical composition comprising anti-ctla4-anti-pd-1 bispecific antibody and chiauranibAKESO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3661US2007043509A1Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding propertiesCARTER DANIEL C·Filed 2004·Application pending·0 cites
- 3761US2025319169A2FUSION PROTEIN CONTAINING ANTI-TIGIT ANTIBODY AND TGF-ßR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOFAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3860US2007219767A1Atomic coordinates of albumin drug complexes and method of use of pharmaceutical developmentCARTER DANIEL C·Filed 2004·Application pending·0 cites
- 3960US2024352153A1Pharmaceutical composition and useAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4058US2025114450A1Pharmaceutical combination containing anti-pd-1-anti-vegfa bispecific antibody, and use thereofAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4158US2024043531A1Anti-cd47 monoclonal antibody and use thereofAKESO BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4257USD974420SHot stamping machineWANG ZHONGMIN·Filed 2021·Granted Jan 3, 2023·2 cites·1 claims
- 4357US2024002504A1Anti-tigit antibody, and pharmaceutical composition and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4457US2024018254A1Anti-cd73 antibody and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4556US2024218074A1Anti-cd73 antibody and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4654US2024199741A1Use of antibody in anti-tumor treatmentAKESO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4754US2023159655A1Anti-cd73 antibody and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4854US2023151111A1Anti-cd73-anti-pd-1 bispecific antibody and use thereofAKESO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4953US2023312750A1Anti-pcsk9 antibody and use thereofAD PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 5053US2011203185A1Painted surface treating composition, a painted surface treating method and a painted surface patching methodWANG ZHONGMIN·Filed 2009·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zhongmin Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →